Clinical values of Barcelona Clinic Liver Cancer subgroup and up-to-7 criteria in intermediate stage hepatocellular carcinoma with transcatheter arterial chemoembolization

Table 3 Overall survivals of the enrolled patients, n (%)

		All, n	≥ 1 yr	≥ 2 yr	≥ 3 yr	P value
							All
128	83 (64.8)	60 (46.9)	40 (31.2)
HCC number						0.629
	2	45	26 (57.8)	19 (42.2)	13 (28.9)
	3-5	36	27 (75.0)	20 (55.6)	15 (41.7)
	> 5	47	30 (63.8)	21 (44.7)	12 (25.5)
HCC size in cm						0.001
	1-5	42	36 (85.7)	29 (69.0)	17 (40.5)
	6-10	59	38 (64.4)	26 (44.1)	19 (32.2)
	> 10	27	9 (33.4)	5 (18.5)	4 (14.8)
Up-to-7 criteria						0.003
	Within	45	36 (80.0)	31 (68.9)	22 (48.9)
	Beyond	83	47 (56.6)	29 (34.9)	18 (21.9)
Subclassification						0.049
	B1	40	12 (30.0)	8 (20.0)	20 (50.0)
	B2	62	39 (62.9)	10 (16.1)	13 (21.0)
	B3	11	8 (72.7)	0	3 (27.3)
	B4	15	9 (60.0)	2 (13.3)	4 (26.7)

P values were analyzed with Pearson’s χ² test. HCC: Hepatocellular carcinoma.